AlzeCure Pharma AB a pharmaceutical company that develops a broad portfolio of small molecule candidate drugs for diseases affecting the central nervous system, with projects in both Alzheimer’s disease and pain, announced that a new scientific article on preclinical results supporting antidepressive effects with NeuroRestore ACD856 has been published.
